Puma Biotechnology Inc
PBYI
Get informed when a big investor buys or sells
+ FollowMarket Cap$453.51M
Close$
$17.48
99.3% upside
Current Fair Value
99.3% upsideUndervalued by 99.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $453.51 Million |
|---|---|
| Enterprise Value | $421.83 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.62 |
| Beta | 1.19 |
| Outstanding Shares | 50,939,946 |
Return
| Return on Equity | 19.22% |
|---|---|
| Return on Assets | 13.82% |
| Return on Invested Capital | 22.67% |
Valuation & Multiples
| P/E Ratio | 16.62 |
|---|---|
| PEG | 41.68 |
| Price to Sales | 2.19 |
| Price to Book Ratio | 4.39 |
| Enterprise Value to Revenue | 1.82 |
| Enterprise Value to EBIT | 13.02 |
| Enterprise Value to Net Income | 15 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$0.04
Average shareholder expectationRevenue Estimate
$53.00 M
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$0.09
Average shareholder expectationRevenue Estimate
$57.50 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 111,100▲ 5.11% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 74.46%▲ 3.79% |
|---|---|
| Total Invested | $241.84M▲ 15.03% |
| Investors Holding | 159▲ 5.00% |
ESG Score
No data